The Nutrigenomics Market segment is distinctly structured across two core dimensions: Technology (Testing) and Application (End-Use). The Technology Segment is dominated by DNA Testing Kits and Services, segmented by genetic analysis method (SNP array, Whole Genome Sequencing, Targeted Panels) and the type of sample collected (saliva, blood). The high volume is driven by affordable SNP array tests for the DTC market.

The Application Segment is segmented into Dietary Advice/Wellness (the largest volume segment) and Chronic Disease Management/Clinical Nutrition (the highest value-per-test segment). End-user segmentation includes Direct-to-Consumer (DTC), which accounts for the majority of volume, and Professional/Clinical (Hospitals, Nutritionists, Genetic Counselors), which drives the high-value, evidence-based segment. Furthermore, the market includes a growing segment for Personalized Supplements and Functional Foods whose sales are directly triggered by genetic test results. The structure emphasizes the market's transition from a niche wellness offering to a clinically integrated diagnostic tool.